Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age
Observational study · 2006
- What was studied
- Type-1 diabetes patients of different ages
- Main finding
- The abstract reports coagulation and fibrinolysis changes during adjunctive Vilon treatment in type 1 diabetes, with weaker responses in older patients with severe disease. These are surrogate outcomes.
Reported findings and study design
Population or model Type-1 diabetes patients of different ages
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Coagulation / fibrinolysis | Reported improvement, with less pronounced effects in older, severely affected patients |
Allocation, sample size and independent effect size are not established from the abstract. Biomarkers are not disease-modifying outcomes; cohort overlap remains unresolved.
Source for these results ↗ · Reviewed 2026-11-05
Study limitations and source details
Study limitations
- The study may share participants with the 2007 diabetes publication.
- Full methods, adverse-event reporting and independent replication remain to be appraised.
Source details
Journal publication
Europe PMC indexed citation and abstract checked. Full original paper not reviewed.
Sources checked
Citation
Kuznik BI, Kolesnichenko LR, Kliuchereva NN, Pinelis IuI, Ryzhak GA, Khamaeva TsB. Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age Advances in gerontology = Uspekhi gerontologii 19():107-115. PMID 17152731